Literature DB >> 15821390

Cardiovascular disease in HIV-positive patients.

Daniel S Kamin, Steven K Grinspoon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15821390     DOI： 10.1097/01.aids.0000166087.08822.bc

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  15 in total

1.  The concurrent validity and responsiveness of the health utilities index (HUI 3) among patients with advanced HIV/AIDS.

Authors:  Bohdan Nosyk; Huiying Sun; Nick Bansback; Daphne P Guh; Xin Li; Paul Barnett; Ahmed Bayoumi; Susan Griffin; Vilija Joyce; Mark Holodniy; Doug K Owens; Aslam H Anis
Journal:  Qual Life Res       Date:  2009-06-27       Impact factor: 4.147

Review 2.  A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trials.

Authors:  Darren J Clayson; Diane J Wild; Paul Quarterman; Isabelle Duprat-Lomon; Maria Kubin; Stephen Joel Coons
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 3.  Behavioral, Metabolic, and Immune Consequences of Chronic Alcohol or Cannabinoids on HIV/AIDs: Studies in the Non-Human Primate SIV Model.

Authors:  Patricia E Molina; Angela M Amedee; Peter Winsauer; Steve Nelson; Gregory Bagby; Liz Simon
Journal:  J Neuroimmune Pharmacol       Date:  2015-03-21       Impact factor: 4.147

4.  Gemfibrozil concentrations are significantly decreased in the presence of lopinavir-ritonavir.

Authors:  Kristin H Busse; Colleen Hadigan; Cheryl Chairez; Raul M Alfaro; Elizabeth Formentini; Joseph A Kovacs; Scott R Penzak
Journal:  J Acquir Immune Defic Syndr       Date:  2009-10-01       Impact factor: 3.731

5.  Relationship of postprandial nonesterified fatty acids, adipokines, and insulin across gender in human immunodeficiency virus-positive patients undergoing highly active antiretroviral therapy.

Authors:  Guijing Lu; Asha Thomas-Geevarghese; Erdembileg Anuurad; Subhashree Raghavan; Robert Minolfo; Bernard Ormsby; Wahida Karmally; Wafaa M El-Sadr; Jeanine Albu; Lars Berglund
Journal:  Metab Syndr Relat Disord       Date:  2009-06       Impact factor: 1.894

6.  Determination of the underlying cause of death in three multicenter international HIV clinical trials.

Authors:  Alan R Lifson; Waldo H Belloso; Cate Carey; Richard T Davey; Daniel Duprez; Wafaa M El-Sadr; Jose M Gatell; Daniela C Gey; Jennifer F Hoy; Eric A Krum; Ray Nelson; Daniel E Nixon; Nick Paton; Court Pedersen; George Perez; Richard W Price; Ronald J Prineas; Frank S Rhame; James Sampson; John Worley
Journal:  HIV Clin Trials       Date:  2008 May-Jun

7.  Lack of an Effect of Ritonavir Alone and Lopinavir-Ritonavir on the Pharmacokinetics of Fenofibric Acid in Healthy Volunteers.

Authors:  Lori A Gordon; Christine Y Malati; Colleen Hadigan; Mary McLaughlin; Raul M Alfaro; Mónica M Calderón; Joseph A Kovacs; Scott R Penzak
Journal:  Pharmacotherapy       Date:  2016-01       Impact factor: 4.705

Review 8.  Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat.

Authors:  Ting Wang; Ru Yi; Linden Ann Green; Sarvesh Chelvanambi; Michael Seimetz; Matthias Clauss
Journal:  Cardiovasc Pathol       Date:  2015-07-09       Impact factor: 2.185

9.  Reduced adipogenic gene expression in thigh adipose tissue precedes human immunodeficiency virus-associated lipoatrophy.

Authors:  Mario Kratz; Jonathan Q Purnell; Patricia A Breen; Katherine K Thomas; Kristina M Utzschneider; Darcy B Carr; Steven E Kahn; James P Hughes; Elizabeth A Rutledge; Brian Van Yserloo; Michi Yukawa; David S Weigle
Journal:  J Clin Endocrinol Metab       Date:  2007-12-18       Impact factor: 5.958

10.  Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials.

Authors:  Alan R Lifson; Waldo H Belloso; Richard T Davey; Daniel Duprez; Jose M Gatell; Jennifer F Hoy; Eric A Krum; Ray Nelson; Court Pedersen; George Perez; Richard W Price; Ronald J Prineas; Frank S Rhame; James H Sampson; John Worley
Journal:  HIV Clin Trials       Date:  2010 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.